Färna Invest Increase Shareholding in Bluefish
PDF Document AttachedFÄRNA INVEST INCREASES ITS SHAREHOLDING IN BLUEFISH PHARMACEUTICALS AB Färna Invest and Serendipity Partners have agreed that Färna Invest acquires Serendipity Partners' total shareholding in Bluefish Pharmaceuticals. “We are very pleased that we were able to increase our shareholding in Bluefish Pharmaceuticals. Our ambition is to prepare Bluefish Pharmaceuticals to be ready for an IPO within the next few years. We will continue to invest further into the company and continue to strengthen Bluefish's European expansion and development of new generic products, ”